Husch Blackwell Launches Psychedelics and Emerging Therapies Practice Group
Cannabis Law Report
MARCH 18, 2022
Similar to the early days of the medical cannabis movement, psychedelic drugs such as MDMA, psilocybin, LSD, ketamine and DMT are being developed for therapeutic use in a complex and difficult legal and regulatory environment. The firm’s multidisciplinary team covers commercial, regulatory and legal requirements spanning U.S. Steve Levine.
Let's personalize your content